Role of


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 May 2020
Historique:
received: 23 03 2020
revised: 26 05 2020
accepted: 26 05 2020
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 2 4 2021
Statut: epublish

Résumé

Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by

Identifiants

pubmed: 32481659
pii: ijms21113840
doi: 10.3390/ijms21113840
pmc: PMC7313056
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Apoptosis Regulatory Proteins 0
Cadherins 0
Claudin-4 0
Enterotoxins 0
Transcription Factors 0
YAP-Signaling Proteins 0
YAP1 protein, human 0
Yap1 protein, rat 0
enterotoxin, Clostridium 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 16H05164
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 17K19923
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 19K16564
Organisme : National Natural Science Foundation of China
ID : 81702723
Organisme : Natural Science Foundation of Jiangsu Education Department Project
ID : 17KJB320010

Références

Cancer Res. 1975 Feb;35(2):287-90
pubmed: 162868
J Clin Invest. 2018 Mar 1;128(3):970-984
pubmed: 29400695
Int J Gynecol Cancer. 2012 Nov;22(9):1585-90
pubmed: 23095775
Arch Biochem Biophys. 2014 Nov 15;562:31-6
pubmed: 25078107
Curr Opin Cell Biol. 2008 Dec;20(6):638-46
pubmed: 18955139
Anaerobe. 2016 Oct;41:18-26
pubmed: 27090847
Vaccine. 2009 Nov 5;27 Suppl 4:D44-7
pubmed: 19837285
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Clin Cancer Res. 2003 Oct 15;9(13):4802-10
pubmed: 14581351
J Biol Chem. 2016 May 27;291(22):11596-607
pubmed: 27048650
Crit Rev Oncol Hematol. 2017 May;113:22-27
pubmed: 28427511
Dev Cell. 2019 Aug 5;50(3):264-282
pubmed: 31386861
Oncotarget. 2018 Dec 21;9(100):37367-37378
pubmed: 30647838
Toxins (Basel). 2010 Jul;2(7):1595-611
pubmed: 22069652
Gut. 2016 Nov;65(11):1829-1837
pubmed: 26264224
Oncoscience. 2017 Aug 1;4(7-8):79-94
pubmed: 28966941
Cell Mol Biol (Noisy-le-grand). 2017 Apr 29;63(4):59-66
pubmed: 28478805
Oncol Lett. 2016 Dec;12(6):4427-4434
pubmed: 28101205
Dev Cell. 2012 Apr 17;22(4):695-702
pubmed: 22516196
Cancer Sci. 2019 Jan;110(1):147-156
pubmed: 30443963
Gastroenterology. 2018 Aug;155(2):383-390.e8
pubmed: 29729257
Oncotarget. 2020 Jan 28;11(4):309-321
pubmed: 32064037
J Gastroenterol Hepatol. 2018 Aug;33(8):1454-1460
pubmed: 29377243
Gastroenterology. 2017 Feb;152(3):533-545
pubmed: 28003097
Am J Pathol. 2000 Nov;157(5):1523-35
pubmed: 11073812
Oncotarget. 2018 Nov 27;9(93):36561-36574
pubmed: 30564297
Gastroenterology. 2016 Apr;150(4):895-902.e5
pubmed: 26677986
Diagn Pathol. 2018 Nov 20;13(1):88
pubmed: 30458818
J Pharmacol Exp Ther. 2005 Jun;313(3):962-82
pubmed: 15900076
PLoS One. 2015 Mar 19;10(3):e0117074
pubmed: 25789658
J Gastroenterol Hepatol. 2019 Oct;34(10):1685-1695
pubmed: 31158302
J Cell Biol. 1999 Oct 4;147(1):195-204
pubmed: 10508866
Cancer Prev Res (Phila). 2017 Apr;10(4):226-234
pubmed: 28096237
Oncogene. 2012 Jan 5;31(1):128-34
pubmed: 21685940
Int J Mol Sci. 2019 Aug 24;20(17):
pubmed: 31450555
Cell Death Dis. 2019 Dec 11;10(12):949
pubmed: 31827075
Int J Oncol. 2015 Aug;47(2):650-6
pubmed: 26043767
Clin Cancer Res. 2011 Mar 1;17(5):1065-74
pubmed: 21123456
Cancer Lett. 2015 Dec 1;369(1):212-21
pubmed: 26342407
Indian J Med Microbiol. 2019 Apr-Jun;37(2):268-277
pubmed: 31745030
Mol Biol Cell. 2016 May 15;27(10):1581-95
pubmed: 27009203
Tissue Barriers. 2015 May 01;3(3):e1037948
pubmed: 26451343
Prostate. 2001 Sep 15;49(1):19-29
pubmed: 11550207
Carcinogenesis. 2009 Oct;30(10):1670-7
pubmed: 19700418
Biochem J. 2010 Dec 15;432(3):461-72
pubmed: 20868367
J Biol Chem. 2005 Dec 23;280(51):42375-82
pubmed: 16236711
Am J Pathol. 2005 Mar;166(3):751-60
pubmed: 15743787
Gastrointest Endosc. 2017 Mar;85(3):590-600
pubmed: 27663716
Dig Dis Sci. 2018 Oct;63(10):2626-2638
pubmed: 29974407
Biol Pharm Bull. 2009 May;32(5):825-31
pubmed: 19420749
Braz J Microbiol. 2015 Oct-Dec;46(4):1135-40
pubmed: 26691472
J Gastroenterol. 2005 Aug;40(8):781-90
pubmed: 16143882
Oncogenesis. 2013 Jul 15;2:e55
pubmed: 23857250
Appl Environ Microbiol. 2000 Mar;66(3):1213-5
pubmed: 10698795
Clin Gastroenterol Hepatol. 2016 Jul;14(7):1056-9
pubmed: 26898652
J Pathol. 2002 Feb;196(2):163-70
pubmed: 11793367
Nat Genet. 2015 Mar;47(3):250-6
pubmed: 25665005
Gut. 2016 Mar;65(3):437-46
pubmed: 25731869
PLoS One. 2015 Jul 17;10(7):e0132435
pubmed: 26186212
Genes Dev. 2016 Jan 1;30(1):1-17
pubmed: 26728553
Pathol Res Pract. 2019 May;215(5):957-962
pubmed: 30738693

Auteurs

Rina Fujiwara-Tani (R)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Kiyomu Fujii (K)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Shiori Mori (S)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Shingo Kishi (S)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Takamitsu Sasaki (T)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Hitoshi Ohmori (H)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Chie Nakashima (C)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Isao Kawahara (I)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Yukiko Nishiguchi (Y)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Takuya Mori (T)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Masayuki Sho (M)

Department of Surgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

Masuo Kondoh (M)

Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University, 6-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

Yi Luo (Y)

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province 226001, China.

Hiroki Kuniyasu (H)

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH